$PDYN
Palladyne AI Corp.

2024 Q2 Form 10-Q Financial Statement

#000095017024055837 Filed on May 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $2.713M $3.441M
YoY Change 112.45% 49.87%
Cost Of Revenue $569.0K $1.886M
YoY Change -39.66% 5.6%
Gross Profit $2.144M $1.555M
YoY Change 541.92% 204.9%
Gross Profit Margin 79.03% 45.19%
Selling, General & Admin $5.671M $5.930M
YoY Change -55.21% -56.0%
% of Gross Profit 264.51% 381.35%
Research & Development $2.348M $2.895M
YoY Change -79.94% -69.21%
% of Gross Profit 109.51% 186.17%
Depreciation & Amortization $200.0K $200.0K
YoY Change -50.0% -50.0%
% of Gross Profit 9.33% 12.86%
Operating Expenses $8.019M $8.825M
YoY Change -67.09% -61.43%
Operating Profit -$5.787M -$7.353M
YoY Change -80.68% -68.29%
Interest Expense $346.0K $372.0K
YoY Change -60.41% -66.15%
% of Operating Profit
Other Income/Expense, Net $2.000K $0.00
YoY Change -118.18% -100.0%
Pretax Income -$5.323M -$7.229M
YoY Change -81.43% -66.34%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$5.323M -$7.229M
YoY Change -81.43% -66.34%
Net Earnings / Revenue -196.2% -210.08%
Basic Earnings Per Share -$0.20 -$0.28
Diluted Earnings Per Share -$0.20 -$0.28
COMMON SHARES
Basic Shares Outstanding 26.60M 25.90M
Diluted Shares Outstanding 26.62M 25.88M

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $25.83M $31.80M
YoY Change -65.63% -66.43%
Cash & Equivalents $25.83M $31.80M
Short-Term Investments $0.00 $0.00
Other Short-Term Assets $1.884M $1.770M
YoY Change -47.58% -64.92%
Inventory $0.00 $0.00
Prepaid Expenses
Receivables $500.0K $408.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $30.53M $35.53M
YoY Change -64.19% -67.84%
LONG-TERM ASSETS
Property, Plant & Equipment $4.605M $4.680M
YoY Change -31.91% -38.7%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $501.0K $410.0K
YoY Change 8.21% -14.76%
Total Long-Term Assets $14.58M $14.88M
YoY Change -58.8% -60.23%
TOTAL ASSETS
Total Short-Term Assets $30.53M $35.53M
Total Long-Term Assets $14.58M $14.88M
Total Assets $45.11M $50.40M
YoY Change -62.61% -65.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $410.0K $758.0K
YoY Change -91.08% -71.42%
Accrued Expenses $2.994M $3.092M
YoY Change -26.06% -47.2%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.716M $5.217M
YoY Change -51.31% -44.52%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $161.0K $277.0K
YoY Change -17.44% -57.45%
Total Long-Term Liabilities $161.0K $277.0K
YoY Change -17.44% -57.45%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.716M $5.217M
Total Long-Term Liabilities $161.0K $277.0K
Total Liabilities $15.30M $16.20M
YoY Change -29.21% -26.79%
SHAREHOLDERS EQUITY
Retained Earnings -$430.8M -$425.4M
YoY Change 22.11% 31.27%
Common Stock $3.000K $3.000K
YoY Change 0.0% -80.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $29.81M $34.20M
YoY Change
Total Liabilities & Shareholders Equity $45.11M $50.40M
YoY Change -62.61% -65.91%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income -$5.323M -$7.229M
YoY Change -81.43% -66.34%
Depreciation, Depletion And Amortization $200.0K $200.0K
YoY Change -50.0% -50.0%
Cash From Operating Activities -$5.797M -$7.236M
YoY Change -70.82% -64.04%
INVESTING ACTIVITIES
Capital Expenditures $143.0K $62.00K
YoY Change -47.62% -84.5%
Acquisitions
YoY Change
Other Investing Activities $0.00 $16.00M
YoY Change -100.0% 49.0%
Cash From Investing Activities -$143.0K $15.94M
YoY Change -100.71% 54.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -27.00K -43.00K
YoY Change -51.79% 514.29%
NET CHANGE
Cash From Operating Activities -5.797M -7.236M
Cash From Investing Activities -143.0K 15.94M
Cash From Financing Activities -27.00K -43.00K
Net Change In Cash -5.967M 8.659M
YoY Change -3113.64% -188.44%
FREE CASH FLOW
Cash From Operating Activities -$5.797M -$7.236M
Capital Expenditures $143.0K $62.00K
Free Cash Flow -$5.940M -$7.298M
YoY Change -70.5% -64.44%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001826681
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.00167
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2024Q1 us-gaap Restructuring Reserve
RestructuringReserve
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2024Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
001-39897
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
Palladyne AI Corp.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-2838301
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
650 South 500 West
CY2024Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 150
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Salt Lake City
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84101
CY2024Q1 dei City Area Code
CityAreaCode
888
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
927-7296
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2024Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
26600000
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31798000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23139000
CY2024Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
0
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
15947000
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
408000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
555000
CY2024Q1 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
1550000
CY2023Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
2034000
CY2024Q1 us-gaap Inventory Net
InventoryNet
0
CY2023Q4 us-gaap Inventory Net
InventoryNet
1065000
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1770000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2323000
CY2024Q1 us-gaap Assets Current
AssetsCurrent
35526000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
45063000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4680000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4842000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9786000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
10092000
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
410000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
429000
CY2024Q1 us-gaap Assets
Assets
50402000
CY2023Q4 us-gaap Assets
Assets
60426000
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
758000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1291000
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3092000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5805000
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1367000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1360000
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
5217000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8456000
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10707000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11036000
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
277000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
29000
CY2024Q1 us-gaap Liabilities
Liabilities
16201000
CY2023Q4 us-gaap Liabilities
Liabilities
19521000
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
165000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
165000000
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26552572
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26552572
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25877865
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25877865
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
3000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
3000
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
459642000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
459113000
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-425443000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-418214000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
34201000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
40905000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
50402000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
60426000
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3441000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2296000
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
1886000
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
1786000
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2895000
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9403000
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5125000
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9735000
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
805000
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3741000
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
819000
CY2024Q1 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
83000
CY2023Q1 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
0
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
10794000
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
25484000
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-7353000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-23188000
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
372000
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1099000
CY2024Q1 pdyn Gain Loss On Warrant Liability
GainLossOnWarrantLiability
-248000
CY2023Q1 pdyn Gain Loss On Warrant Liability
GainLossOnWarrantLiability
-436000
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1049000
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7229000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21476000
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7229000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-21476000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.84
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.84
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25879043
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25879043
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25471288
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25471288
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-7229000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-21476000
CY2024Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-4000
CY2023Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
59000
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
59000
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7233000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21417000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
144450000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2664000
CY2023Q1 pdyn Shares Repurchased For Payment Of Tax Withholdings And Other Value
SharesRepurchasedForPaymentOfTaxWithholdingsAndOtherValue
35000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
59000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-21476000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
125732000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
40905000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
571000
CY2024Q1 pdyn Shares Repurchased For Payment Of Tax Withholdings And Other Value
SharesRepurchasedForPaymentOfTaxWithholdingsAndOtherValue
-42000
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-7229000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
34201000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-7229000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-21476000
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
571000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2664000
CY2024Q1 us-gaap Depreciation
Depreciation
201000
CY2023Q1 us-gaap Depreciation
Depreciation
425000
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
819000
CY2024Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
248000
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
436000
CY2024Q1 us-gaap Investment Income Amortization Of Discount
InvestmentIncomeAmortizationOfDiscount
57000
CY2023Q1 us-gaap Investment Income Amortization Of Discount
InvestmentIncomeAmortizationOfDiscount
694000
CY2024Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
83000
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-147000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
448000
CY2024Q1 pdyn Increase Decrease In Unbilled Receivables Under Changes In Operating Assets
IncreaseDecreaseInUnbilledReceivablesUnderChangesInOperatingAssets
-484000
CY2023Q1 pdyn Increase Decrease In Unbilled Receivables Under Changes In Operating Assets
IncreaseDecreaseInUnbilledReceivablesUnderChangesInOperatingAssets
-1840000
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1065000
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2496000
CY2024Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-553000
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
32000
CY2024Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-325000
CY2023Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-300000
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-511000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-986000
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2787000
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-160000
CY2024Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-329000
CY2023Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-314000
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7236000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-20122000
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
62000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
400000
CY2024Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
0
CY2023Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
29262000
CY2024Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
16000000
CY2023Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
40000000
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
15938000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
10338000
CY2024Q1 pdyn Shares Repurchased For Payment Of Tax Withholdings
SharesRepurchasedForPaymentOfTaxWithholdings
42000
CY2023Q1 pdyn Shares Repurchased For Payment Of Tax Withholdings
SharesRepurchasedForPaymentOfTaxWithholdings
6000
CY2024Q1 pdyn Payment Of Obligations Under Capital Leases
PaymentOfObligationsUnderCapitalLeases
1000
CY2023Q1 pdyn Payment Of Obligations Under Capital Leases
PaymentOfObligationsUnderCapitalLeases
1000
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-43000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-7000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8659000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-9791000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23139000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
35159000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31798000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25368000
CY2024Q1 pdyn Purchase Of Property And Equipment Included In Accounts Payable
PurchaseOfPropertyAndEquipmentIncludedInAccountsPayable
14000
CY2023Q1 pdyn Purchase Of Property And Equipment Included In Accounts Payable
PurchaseOfPropertyAndEquipmentIncludedInAccountsPayable
58000
CY2023Q3 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-6 reverse stock split
CY2024Q1 pdyn Cash Cash Equivalents And Marketable Securities
CashCashEquivalentsAndMarketableSecurities
31800000
CY2023Q4 pdyn Cash Cash Equivalents And Marketable Securities
CashCashEquivalentsAndMarketableSecurities
39100000
CY2024Q1 pdyn Retained Earning Accumlated Deficit
RetainedEarningAccumlatedDeficit
-425400000
CY2024Q1 pdyn Working Capital
WorkingCapital
30300000
CY2024Q1 us-gaap Revenues
Revenues
3441000
CY2023Q1 us-gaap Revenues
Revenues
2296000
CY2023Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss Current
ContractWithCustomerReceivableAfterAllowanceForCreditLossCurrent
555000
CY2023Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
2034000
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
50000
CY2023Q4 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
1000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
75000
CY2024Q1 pdyn Increase Decrease In Accounts Receivable Inclusive Of Accounts Receivable Acquired In Business Combination
IncreaseDecreaseInAccountsReceivableInclusiveOfAccountsReceivableAcquiredInBusinessCombination
-147000
CY2024Q1 pdyn Increase Decrease Unbilled Receivable
IncreaseDecreaseUnbilledReceivable
-484000
CY2024Q1 pdyn Increase Decrease In Contract Assets Current
IncreaseDecreaseInContractAssetsCurrent
1000
CY2024Q1 pdyn Increas Decrease In Contract Assets Long Term
IncreasDecreaseInContractAssetsLongTerm
-1000
CY2024Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
170000
CY2024Q1 us-gaap Contract With Customer Receivable After Allowance For Credit Loss Current
ContractWithCustomerReceivableAfterAllowanceForCreditLossCurrent
408000
CY2024Q1 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
1550000
CY2024Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
51000
CY2024Q1 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
0
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
245000
CY2024Q1 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
0
CY2023Q1 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
0
CY2023Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
4200000
CY2024Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
14954000
CY2024Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
277000
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
20920000
CY2023Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
29000
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
15000000
CY2024Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
0
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1065000
CY2024Q1 us-gaap Inventory Net
InventoryNet
0
CY2023Q4 us-gaap Inventory Net
InventoryNet
1065000
CY2024Q1 us-gaap Prepaid Insurance
PrepaidInsurance
697000
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
873000
CY2024Q1 pdyn Other Prepaid Expenses And Assets
OtherPrepaidExpensesAndAssets
310000
CY2023Q4 pdyn Other Prepaid Expenses And Assets
OtherPrepaidExpensesAndAssets
422000
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1770000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2323000
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7219000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9109000
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2539000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4267000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4680000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4842000
CY2024Q1 us-gaap Depreciation
Depreciation
200000
CY2023Q1 us-gaap Depreciation
Depreciation
400000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
11.62
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1682000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3913000
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
506000
CY2024Q1 pdyn Legal Services Accrual
LegalServicesAccrual
160000
CY2023Q4 pdyn Legal Services Accrual
LegalServicesAccrual
547000
CY2024Q1 pdyn Other Accrued Expenses And Current Liabilities
OtherAccruedExpensesAndCurrentLiabilities
1250000
CY2023Q4 pdyn Other Accrued Expenses And Current Liabilities
OtherAccruedExpensesAndCurrentLiabilities
839000
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3092000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5805000
CY2024Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
20549453
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2845084
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.82
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7DT4H
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
91000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
20000
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.81
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1113918
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
13.05
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1751166
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.67
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y9M18D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
257000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1250104
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
91000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1264352
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
7.78
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y8M12D
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
257000
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
571000
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2664000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-7229000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-21476000
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25879043
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25879043
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25471288
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25471288
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.84
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.84
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12237740
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13824568
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2024Q1 pdyn Defined Contribution Plan Maximum Deferred Compensation By Employees Percentage
DefinedContributionPlanMaximumDeferredCompensationByEmployeesPercentage
1
CY2023 pdyn Defined Contribution Plan Maximum Deferred Compensation By Employees Percentage
DefinedContributionPlanMaximumDeferredCompensationByEmployeesPercentage
1
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-055837-index-headers.html Edgar Link pending
0000950170-24-055837-index.html Edgar Link pending
0000950170-24-055837.txt Edgar Link pending
0000950170-24-055837-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pdyn-20240331.htm Edgar Link pending
pdyn-20240331.xsd Edgar Link pending
pdyn-ex10_1.htm Edgar Link pending
pdyn-ex10_10.htm Edgar Link pending
pdyn-ex10_11.htm Edgar Link pending
pdyn-ex10_12.htm Edgar Link pending
pdyn-ex10_13.htm Edgar Link pending
pdyn-ex10_14.htm Edgar Link pending
pdyn-20240331_htm.xml Edgar Link completed
pdyn-ex10_15.htm Edgar Link pending
pdyn-ex10_16.htm Edgar Link pending
pdyn-ex10_6.htm Edgar Link pending
pdyn-ex10_7.htm Edgar Link pending
pdyn-ex10_9.htm Edgar Link pending
pdyn-ex31_1.htm Edgar Link pending
pdyn-ex31_2.htm Edgar Link pending
pdyn-ex32_1.htm Edgar Link pending
pdyn-ex32_2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable